Amer Karam

3.0k total citations
61 papers, 1.3k citations indexed

About

Amer Karam is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Amer Karam has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 21 papers in Obstetrics and Gynecology and 18 papers in Surgery. Recurrent topics in Amer Karam's work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Breast Cancer Treatment Studies (9 papers). Amer Karam is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Breast Cancer Treatment Studies (9 papers). Amer Karam collaborates with scholars based in United States, France and Australia. Amer Karam's co-authors include Oliver Dorigo, Beth Y. Karlan, Christine H. Holschneider, Nancy Feldman, Chintda Santiskulvong, Carol Eng, Michelle Stempel, Hiram S. Cody, Elisa Port and Diana P. English and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Amer Karam

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amer Karam United States 19 445 333 301 274 262 61 1.3k
Christopher S. Awtrey United States 16 229 0.5× 416 1.2× 442 1.5× 245 0.9× 183 0.7× 31 1.3k
Jean Lévêque France 24 478 1.1× 267 0.8× 400 1.3× 545 2.0× 610 2.3× 142 2.2k
Maria Sotiropoulou Greece 18 181 0.4× 145 0.4× 254 0.8× 221 0.8× 343 1.3× 113 1.0k
Lobna Ouldamer France 19 208 0.5× 144 0.4× 549 1.8× 671 2.4× 372 1.4× 147 1.4k
Yeşim Eralp Türkiye 21 555 1.2× 186 0.6× 168 0.6× 113 0.4× 198 0.8× 94 1.3k
Giorgio Giorda Italy 23 306 0.7× 158 0.5× 879 2.9× 613 2.2× 500 1.9× 95 1.5k
James E. Wheeler United States 27 392 0.9× 213 0.6× 933 3.1× 593 2.2× 332 1.3× 61 2.2k
Serena Wong United States 18 272 0.6× 168 0.5× 132 0.4× 132 0.5× 79 0.3× 47 786
Linn Woelber Germany 23 387 0.9× 228 0.7× 200 0.7× 639 2.3× 676 2.6× 82 1.5k
Noreen Gleeson Ireland 24 271 0.6× 454 1.4× 453 1.5× 516 1.9× 454 1.7× 103 1.9k

Countries citing papers authored by Amer Karam

Since Specialization
Citations

This map shows the geographic impact of Amer Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer Karam more than expected).

Fields of papers citing papers by Amer Karam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amer Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer Karam. The network helps show where Amer Karam may publish in the future.

Co-authorship network of co-authors of Amer Karam

This figure shows the co-authorship network connecting the top 25 collaborators of Amer Karam. A scholar is included among the top collaborators of Amer Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amer Karam. Amer Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Susan M., Filippos Vingopoulos, Sahana Somasegar, et al.. (2025). Early experience and assessment of real-world toxicities with mirvetuximab soravtansine in a heavily pretreated patient cohort with ovarian cancer. Gynecologic Oncology Reports. 59. 101738–101738. 1 indexed citations
2.
Hui, Caressa, Rie von Eyben, Oliver Dorigo, et al.. (2023). Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma?. Gynecologic Oncology. 177. 150–156. 3 indexed citations
3.
Liu, Caroline, Oliver Dorigo, Babak Litkouhi, et al.. (2023). Aberrant nuclear β-catenin distribution does not prognosticate recurrences of endometrioid endometrial cancers – A retrospective single-institutional study. Gynecologic Oncology. 179. 85–90. 4 indexed citations
4.
Fader, Amanda N., Warner K. Huh, Joshua P. Kesterson, et al.. (2021). When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations During the COVID-19 Pandemic. Obstetrical & Gynecological Survey. 76(2). 88–90. 3 indexed citations
5.
Devereaux, Kelly A., Jennifer Pors, David F. Steiner, et al.. (2021). Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience. Modern Pathology. 35(5). 688–696. 37 indexed citations
6.
Rahimy, Elham, Rie von Eyben, Amer Karam, et al.. (2021). Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors. Gynecologic Oncology. 161(1). 275–281. 7 indexed citations
7.
Zighelboim, Israel, et al.. (2021). Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement. Gynecologic Oncology. 163(3). 448–452. 8 indexed citations
8.
Karam, Amer, et al.. (2019). Acute Optic Neuritis Diagnosed by Bedside Ultrasound in an Emergency Department. Journal of Emergency Medicine. 57(2). 207–211. 2 indexed citations
9.
Renz, Malte, Nicole A. Marjon, Kelly A. Devereaux, et al.. (2019). Immediate intraoperative sentinel lymph node analysis by frozen section is predictive of lymph node metastasis in endometrial cancer. Journal of Robotic Surgery. 14(1). 35–40. 14 indexed citations
10.
Brubaker, Lindsay W., et al.. (2015). Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma. International Journal of Gynecological Pathology. 35(1). 72–77. 4 indexed citations
11.
Shah, Galaxy, Lorna Kwan, Jeffrey S. Montgomery, et al.. (2014). Video-based Peer Feedback Through Social Networking for Robotic Surgery Simulation. Annals of Surgery. 261(5). 870–875. 41 indexed citations
12.
13.
Karam, Amer. (2012). Update on breast cancer surgery approaches. Current Opinion in Obstetrics & Gynecology. 25(1). 74–80. 5 indexed citations
14.
Karam, Amer & Oliver Dorigo. (2012). MMPs in Ovarian Cancer as Therapeutic Targets. Anti-Cancer Agents in Medicinal Chemistry. 12(7). 764–772. 18 indexed citations
15.
Santiskulvong, Chintda, Gottfried E. Konecny, Kuang-Yui Michael Chen, et al.. (2011). Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma. Clinical Cancer Research. 17(8). 2373–2384. 100 indexed citations
16.
Lu, David, et al.. (2011). Genital rhabdomyoma of the urethra in an infant girl. Human Pathology. 43(4). 597–600. 6 indexed citations
17.
Karam, Amer, Meier Hsu, Sujata Patil, et al.. (2009). Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes. Annals of Surgical Oncology. 16(7). 1952–1958. 5 indexed citations
18.
Karam, Amer, Michelle Stempel, Hiram S. Cody, & Elisa Port. (2008). Reoperative Sentinel Lymph Node Biopsy after Previous Mastectomy. Journal of the American College of Surgeons. 207(4). 543–548. 49 indexed citations
19.
Karam, Amer, Nancy Feldman, & Christine H. Holschneider. (2007). Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nature Clinical Practice Oncology. 4(6). 375–380. 63 indexed citations
20.
Karam, Amer. (2003). Argon beam coagulation facilitates management of placenta percreta with bladder invasion. Obstetrics and Gynecology. 102(3). 555–556. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026